The effect of furosemide infusion on serum epidermal growth factor concentration after acute lung injury

Journal of Infusion Nursing

Volumn 28, Issue 3, 2005, Pages 188-193

  Mojtahedzadeh, Mojtaba ^a   Vazin, Afsaneh ^b   Najafi, Atabak ^a   Khalilzadeh, Azita ^a   Abdollahi, Mohammad ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR; FUROSEMIDE;

ACUTE LUNG INJURY; ADULT RESPIRATORY DISTRESS SYNDROME; ARTERIAL OXYGEN TENSION; CLINICAL TRIAL; CONTINUOUS INFUSION; DRUG EFFECT; DRUG MECHANISM; ENZYME LINKED IMMUNOSORBENT ASSAY; HEART RATE; HEMODYNAMICS; HOSPITALIZATION; HUMAN; INFUSION; LUNG ARTERIOVENOUS SHUNT; LUNG GAS EXCHANGE; MEAN ARTERIAL PRESSURE; OXYGENATION; PNEUMONIA; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REVIEW; TREATMENT OUTCOME;

EID: 18444373910     PISSN: 15331458     EISSN: None     Source Type: Journal    
DOI: 10.1097/00129804-200505000-00007     Document Type: Review

References (22)

1. Dhainaut JF, Brower RG, Russell JA. Introduction to the forth Margaux conference on critical illness: acute lung injury: understanding the mechanisms of injury and repair. Crit Care Med. 2003;31:183.
2. Reising CA, Chendrasekhar A, Burt E. Continuous-dose furosemide attenuates TNF levels in acute respiratory distress syndrome (ARDS). J App Res. 2003;3:249-253.
3. Subauste MC, Proud D. Effects of tumor necrosis factor-alpha, epidermal growth factor and transforming growth factor-alpha on interleukin-8 production by, and human rhinovirus replication in, bronchial epithelial cells. Int Immunopharmacol. 2001;1(7):1229-1234.
4. Demling RH. Role of mediators in human ARDS. J Crit Care. 1988;3:56.
5. Bernard GR, Reines HD, Halushka PV, et al. Prostacyclin and thromboxane A2 formation is increased in human sepsis syndrome. effects of cyclooxygenase inhibition. Am Rev Respir Dis. 1991;144(5):1095-1101.
6. Bernard GR, Luce JM, Sprung CL, et al. High-dose corticosteroids in patients with the adult respiratory distress syndrome. N Engl J Med. 1987;317(25):1565-1570.
7. Meduri GU, Chinn AJ, Leeper KV, et al. Corticosteroid rescue treatment of progressive fibroproliferation in late ARDS: patterns of response and predictors of outcome. Chest. 1994;105(5):1516-1527.
8. Ali J, Chernicki W, Wood LD. Effect of furosemide in canine low-pressure pulmonary edema. J Clin Invest. 1979;64(5):1494-1504.
9. Ali J, Unruh H, Skoog C, Goldberg HS. The effect of lung edema on pulmonary vasoactivity of furosemide. J Surg Res. 1983;35(5):383-390.
10. Ali J, Wood LD. Pulmonary vascular effects of furosemide on gas exchange in pulmonary edema. J Appl Physiol. 1984;57(1):160-167.
11. Reising CA, Chendrasekhar A, Wall PL, Paradise NF, Timberlake GA, Moorman DW. Continuous-dose furosemide as a therapeutic approach to acute respiratory distress syndrome (ARDS). J Surg Res. 1999;82(1):56-60.
12. Yuengsrigul A, Chin TW, Nussbaum E. Immunosuppressive and cytotoxic effects of furosemide on human peripheral blood mononuclear cells. Ann Allergy Asthma Immunol. 1999;83(6 Pt 1):559-566.
13. Bianco S, Vaghi A, Robuschi M, Pasargiklian M. Prevention of exercise-induced bronchoconstriction by inhaled furosemide. Lancet. 1988;2(8605):252-255.
14. Grubbe RE, Hopp R, Dave NK, Brennan B, Bewtra A, Townley R. Effect of inhaled furosemide on the bronchial response to methacholine and cold-air hyperventilation challenges. J Allergy Clin Immunol. 1990;85(5):881-884.
15. Bianco S, Pieroni MG, Refini RM, Rottoli L, Sestini P. Protective effect of inhaled furosemide on allergen-induced early and late asthmatic reactions. N Engl J Med. 1989;321(16):1069-1073.
16. Knause WA, Draper EA, Wagner DP, Zimmerman JE. APACE II: a severity of disease classification system. Crit Care Med. 1985;13:818-829.
17. Goss CH, Brower RG, Hudson LD, Hudson LD, Rubenfeld GD, ARDS Network. Incidence of acute lung injury in the United States. Crit Care Med. 2003;31:1607-1611.
18. Martin GS, Mangialardi RJ, Wheeler AP, Dupont WD, Morris JA, Bernard GR. Albumin and furosemide therapy in hypoproteinemic patients with acute lung injury. Crit Care Med. 2002;(10):2175-2182.
19. Martin GS. Fluid balance and colloid osmotic pressure in acute respiratory failure: emerging clinical evidence. Crit Care. 2000;4(Suppl 2):S21-S25.
20. Pai VB, Nahata MC. Aerosolized furosemide in the treatment of acute respiratory distress and possible bronchopulmonary dysplasia in preterm neonates. Ann Pharmacother. 2000;34(3):386-392.
21. Demling RH, Will JA. The effect of furosemide on the pulmonary transvascular fluid filtration rate. Crit Care Med. 1978;6(5):317-319.
22. Schuster CJ, Weil MH, Besso J, Carpio M, Henning RJ. Blood volume following diuresis induced by furosemide. Am J Med. 1984;76(4):585-592.